VBI Vaccines Inc. (Nasdaq: VBIV) (TSX:VBV) (VBI) today announced that Jeff Baxter, President and CEO, will present at the BMO Capital Markets Prescriptions for Success Healthcare Conference on Thursday, December 14, 2017, at 11:00 AM ET in New York.
The presentation will be webcast live and can be accessed through the below link or through the Investors page of VBI’s website at: www.vbivaccines.com/investors/events-presentations/. A replay of the presentation will be available at the same location for 90 days following the conference.
- Event: BMO Capital Markets Prescriptions for Success Healthcare Conference
- Date: Thursday, December 14, 2017
- Time: 11:00 – 11:30 AM ET
- Event Website: https://www.bmocm.com/conferences/
- Webcast: http://bit.ly/bmo-2017
Nicole Anderson, Communications Executive
Phone: (617) 830-3031 x124
VBI Investor Contact
Nell Beattie, Chief Business Officer
Phone: (617) 830-3031 x128
VBI Media Contact
Matt Middleman, M.D.
LifeSci Public Relations
Phone: (646) 627-8384
Cautionary Statement on Forward-looking Information
Certain statements in this press release that are forward-looking and not statements of historical fact are forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are forward-looking information within the meaning of Canadian securities laws (collectively, “forward-looking statements”). The company cautions that such statements involve risks and uncertainties that may materially affect the company’s results of operations. Such forward-looking statements are based on the beliefs of management as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to prevailing market conditions A discussion of these and other factors, including risks and uncertainties with respect to the company, is set forth in the Company’s filings with the Securities and Exchange Commission and the Canadian securities authorities, including its Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 20, 2017, and filed with the Canadian security authorities at sedar.com on March 24, 2017, as may be supplemented or amended by the Company’s Quarterly Reports on Form 10-Q. Given these risks, uncertainties and factors, you are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. All such forward-looking statements made herein are based on our current expectations and we undertake no duty or obligation to update or revise any forward-looking statements for any reason, except as required by law.